Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
A study published analyzes the effectiveness of a low-carbohydrate diet in patients with fatty liver disease. Results show weight loss, reduced abdominal circumference, and improvements in liver inflammation and glucose metabolism.
Orforglipron, an oral GLP-1 small molecule, shows significant weight loss results and may become an alternative to injectable drugs like Ozempic or Wegovy.
Hydronidone has demonstrated significant reversal of liver fibrosis in patients with chronic hepatitis B, offering a potential new therapeutic option.
HU6 is a novel oral drug that reduces liver fat and body weight through controlled metabolic acceleration, showing promising results in clinical trials compared to placebo.
A large study shows that daily alcohol consumption, even in small amounts, worsens liver fibrosis in patients with metabolic liver disease.
A large study reveals that vitamin E can reduce liver fibrosis and improve liver health in patients, reinforcing its therapeutic value alongside diet and exercise.
A misdiagnosed case between primary biliary cholangitis and mild adult idiopathic ductopenia shows why obtaining a second medical opinion is essential in biliary duct disorders.
Frequent snoring is linked to a higher risk of fatty liver disease, independent of obesity or diabetes, underscoring the role of proper sleep in liver health.
15 de November de 2018
30 de June de 2021
30 de January de 2023
Hepatitis A is an acute inflammatory disease of the liver, caused by infection with hepatitis A virus (VAH).
It is the second cause of liver transplantation in the USA and in the next 10 years is expected to be the first cause. It is a serious illness if it is not treated properly.
It is a chronic progressive liver disease that mainly affects women (90% of cases) from the fourth decade of life.